Back to search

Democritus University of Thrace (DUTH)

Παραγωγή και έλεγχος βιοδραστικότητας ανασυνδυασμένων πολυπεπτιδίων με φαρμακευτική δράση

Abstract

dc:description

In this study three polypeptide biopharmaceuticals with increasing research and economic interest were investigated: Interleukin-2 (IL-2), Erythropoietin (Epo) and Interferon alpha 2a (IFNα2a). Specifically, in cancer immunotherapy clinical approaches IL-2 is used as an anticancer agent to treat melanoma and metastatic kidney cancer, while Εpo is administered to patients with severe chronic kidney diseases, HIV and cancer patients receiving chemotherapy or to treat anemia. IFNα2a has been approved for the treatment of hairy cell leukemia, chronic hepatitis B and C virus infection (HBV & HCV), chronic myeloid leukemia (CML), renal cell carcinoma, Kaposi’s sarcoma, T-cell lymphoma, multiple myeloma and condyloma acuminata. Currently, these polypeptide drugs are expressed and purified as recombinant proteins in bacteria (in case of Epo, mammalian cells) and are available as injectable lyophilized powder. We used state-of-the-art protein expression technology in yeast cell systems and the 3 polypeptide drugs were formulated in various pharmaceutical forms aiming to improve the drug release kinetics (biobetters). First, we cloned the synthetic genes encoding the human mature IL-2, Epo and IFNα2a using the P. pastoris codon bias in specific vectors with removable affinity tags. The purification of the secreted tagged proteins was conducted with affinity chromatography. We managed to isolate recombinant IL-2 and IFNα2a. Free from the tags, the human mature IL-2 and IFNα2a were collected after treatment with TEV protease, followed by a second cycle of affinity chromatography. We further investigated the potential immunogenicity of these recombinant proteins at a preclinical level. A three-prong approach was followed. First, we performed an extensive in silico analysis using databases, such as the Immune Epitope Database (IEDB) and SYFPEITHI, in order to predict interactions with common HLA epitopes. The findings of the in silico studies were then experimentally confirmed by immunoassays, such as enzyme-linked immunosorbent assay (ELISA). Furthermore, we conducted a comparative in vitro study of the immunogenicity of the 2 polypeptides in peripheral monocytes (PBMCs) from healthy donors. More specifically, we examined the stimulation of T-cells, as monitored after CFSE labeling and FACS analysis, as well as the levels of cytokine secretion (IFN-γ, IL-2, IL-4, IL-10). Using state-of-the art technology, our polypeptide was used to develop new pharmaceutical forms: hydrogels and PLGA microspheres. Hydrogels turned out to be a more effective pharmaceutical form. The structural stability and right folding of the mature polypeptides as well as their pharmaceutical forms were also confirmed with circular dichroism and DSF (Differential Scanning Fluorimetry). Then, the biological activity of the recombinant IFNα2a and IL-2 and their pharmaceutical forms was assessed and compared to that of the corresponding prescribed as medication drugs. Real-time PCR revealed that IFNα2a produced by Pichia pastoris, induced the up-regulation of various interferon stimulated genes (ISGs) such as MX1, OAS1, IFIT1, IFIT3 and TRAIL in A549 and HT29 cell lines. In case of IL-2, our results showed a mild increase in the transcriptional levels of the Cyclin D2, Bcl-2, FASLG, IL2RA, SOCS-2 and TNFα genes, but at the same levels as commercially available IL-2. Finally, bioavailability and pharmacokinetics were evaluated in vivo in mice, indicating higher bioavailability of the hydrogel pharmaceutical form.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chronopoulou, Sofia
  • Χρονοπούλου, Σοφία

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61326

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chronopoulou, Sofia; Χρονοπούλου, Σοφία. Παραγωγή και έλεγχος βιοδραστικότητας ανασυνδυασμένων πολυπεπτιδίων με φαρμακευτική δράση. Democritus University of Thrace (DUTH), 2026. http://hdl.handle.net/10442/hedi/61326